• On sale!
search

IRIDINA ANTISTAMIN * COLL 10 + 8MG

  • Montefarmaco OTC S.p.A.
  • 034281016
Iridina Antihistamine is a drug based on the active ingredient naphazoline + tonzilamine, belonging to the category of decongestants and specifically Sympathomimetics used as decongestants. Iridina Antihistamine can be prescribed with OTC Recipe - self-medication. Allergic and inflammatory states of the conjunctiva, accompanied by photophobia, lacrimation, sensation of foreign bodies.
info_outline View product sheet
Final Price €8.90

Volume discounts

Quantity Unit discount You Save
2 10% €1.78
5 15% €6.68
10 25% €22.25
Quantity
warning Last items in stock
Shipped within 24 h
  Convenient and safe payments

Even with a credit card

  Shipping in 24h all over the world

Fast and safe international shipping worldwide

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service. Experts in international shipping

Other products Others products at unbeatable price

Montefarmaco OTC S.p.A.

Discover all products

IRIDINA ANTISTAMIN * COLL 10 + 8MG

Therapeutic indications

Allergic and inflammatory states of the conjunctiva, accompanied by photophobia, lacrimation, sensation of foreign bodies.

Dosage and method of use

Instill 1-2 drops into the affected eye, up to 2-3 times a day, as needed. Strictly adhere to the recommended doses. A higher dosage of the product even if taken topically and for a short period of time can give rise to serious systemic effects. If symptoms persist or worsen after a short period of treatment, consult your doctor. In any case, the product should not be used for more than 4 consecutive days, unless otherwise prescribed, as undesirable effects may occur.

Contraindications

The product is contraindicated in patients with hypersensitivity to one of the components, in patients with narrow-angle glaucoma or with other severe eye diseases. Contraindicated in children under 12 years. Simultaneous treatment with monoamine oxidase inhibitors (see section 4.5).

Side effects

The use of the product can sometimes cause pupillary dilation, systemic effects from absorption (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case it is necessary to interrupt the treatment and consult the doctor so that, if necessary, appropriate therapy can be instituted. The patient is invited to report to the attending physician or pharmacist the possible occurrence of undesirable effects not described.

Special warnings

The product, although presenting a very poor systemic absorption, should be used with caution in patients suffering from hypertension, hyperthyroidism, cardiac disorders, bronchial asthma and hyperglycemia (diabetes). Infections, pus, foreign bodies in the eye, mechanical, chemical, heat damage require medical attention. soft contact. Keep out of reach of children as accidental ingestion can cause CNS depression (marked sedation and hypotonia). In these cases, immediate medical attention is always required.

Pregnancy and breastfeeding

During pregnancy and lactation use only in case of real need, under the direct supervision of the doctor.

Expiration and retention

Do not store above 30 ° C. Keep the bottle in the outer carton to protect the medicine from light. The shelf life after first opening the bottle is: 28 days.

Interactions with other drugs

IRIDINA ANTHISTAMINE should not be used by subjects being treated with antidepressant drugs (MAOIs) and in the two weeks following such treatment as severe hypertensive crises may appear.

Overdose

Strictly adhere to the recommended doses. The product, if accidentally ingested or if used for a long time in excessive doses, can cause toxic phenomena, especially in children. Accidental ingestion of the drug can cause CNS depression up to coma, especially in children. In these cases, immediate medical assistance is always required: gastric lavage, sedation with diazepam and general support measures.

Active principles

1 bottle of 10 ml contains: • 10 mg tonzylamine hydrochloride • 8 mg naphazoline nitrate Excipients: contains: benzalkonium chloride. For the full list of excipients, see section 6.1.

Excipients

Sodium chloride, Sodium citrate, Citric acid monohydrate, Sodium edetate, Benzalkonium chloride, Water for injections.

034281016

Data sheet

Packaging
eye drops 10 ml
Product Type
HUMAN DRUG
ATC code
S01GA51
ATC description
Nafazolina, associations
Therapeutic Group
Decongestants
Active principle
naphazoline + tonzylamine
Class
C.
Pharmaceutical form
eye drops
Type of Administration
ophthalmic
Container
vial / bottle / vial in box
Quantity
1 vial / vial / vial
Capacity
10 milliliters
Recipe required
OTC - self-medication medicine
chat Comments (0)
Fast Order